PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C: Submission to the National Institute for Health and Clinical Excellence (NICE)
Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.767
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2012
Authors
Publisher
Elsevier BV